Medivate Partners is a private equity and venture capital firm that focuses investment in biotech/healthcare industry in Asia and North America. The firm is well positioned to capture surging healthcare investment opportunities between Asia and North America, and looks to arbitrage the unique cross border investment advantages. While closing its second fund, Medivate Partners quickly built a reputation for providing inner circle access to top caliber syndicates and successful life science deals in Asia and North America.
View Top Employees from Medivate PartnersWebsite | http://www.medivatepartners.com/en/html/main.html |
Revenue | $6.6 million |
Employees | 6 (5 on RocketReach) |
Founded | 2012 |
Address | 15f Kwangil Seocho Gu Plz 331, Seoul 06627, KR |
Phone | (822) 536-0704 |
Technologies |
JavaScript,
Nginx,
Google Maps
+2 more
(view full list)
|
Industry | Venture Capital and Private Equity Principals, Finance General, Biotech/Healthcare Investment, Finance, Private Equity Fund, Venture Capital, Growth Capital |
SIC | SIC Code 67 Companies, SIC Code 679 Companies |
NAICS | NAICS Code 52 Companies, NAICS Code 5239 Companies, NAICS Code 523 Companies |
Looking for a particular Medivate Partners employee's phone or email?
The Medivate Partners annual revenue was $6.6 million in 2023.
Paul Kim is the Managing Director of Medivate Partners.
5 people are employed at Medivate Partners.
The NAICS codes for Medivate Partners are [52, 5239, 523].
The SIC codes for Medivate Partners are [67, 679].